Phentermine And Topiramate Capsule, Extended Release
Product Images NDC 66993-780

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Phentermine And Topiramate (NDC 66993-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Phentermine And Topiramate Extended Release Capsul 1)

Chemical structure diagram of phentermine hydrochloride, showing its molecular arrangement including a benzene ring, amine group, and associated hydrochloride (HCl) component.*

FDA Label Image

Chemical Structure (Phentermine And Topiramate Extended Release Capsul 2)

Chemical structure diagram of the active ingredients in phentermine and topiramate. The image depicts molecular bonds and functional groups characteristic of this combination drug.*

FDA Label Image

12 (Phentermine And Topiramate Extended Release Capsul 3)

Two line graphs showing percent weight loss from baseline to week 56 in adults with obesity from two studies. Study 1 compares placebo, phentermine/topiramate extended release 3.75 mg/23 mg, and 15 mg/92 mg doses. Study 2 compares placebo, phentermine/topiramate extended release 7.5 mg/46 mg, and 15 mg/92 mg doses in adults with obesity or overweight with co-morbidities. Weight loss increases over time for drug doses versus placebo in both studies.*

FDA Label Image

123 (Phentermine And Topiramate Extended Release Capsul 4)

A line graph showing BMI percent change from baseline over 56 weeks plus ITT washout period for phentermine and topiramate extended-release capsules. Three groups are compared: placebo, PHEN/TOP ER 7.5 mg/46 mg, and PHEN/TOP ER 15 mg/92 mg. The x-axis represents time in weeks, and the y-axis shows BMI percent change. PHEN/TOP groups show a decrease in BMI over time, with the 15 mg/92 mg dose showing the greatest reduction.*

FDA Label Image

234 (Phentermine And Topiramate Extended Release Capsul 5)

Images of four phentermine and topiramate extended-release capsules in different strengths, each capsule is imprinted with 'VIVUS' and the corresponding dosage. The 3.75 mg/23 mg capsule is purple with white printing; the 7.5 mg/46 mg capsule is half purple with white printing and half yellow with black printing; the 11.25 mg/69 mg capsule is yellow with black printing; the 15 mg/92 mg capsule is yellow with black printing and white body.*

FDA Label Image

3.75 (Phentermine And Topiramate Extended Release Capsul 6)

Label for phentermine and topiramate extended-release capsules, strength 3.75 mg/23 mg, by Prasco Laboratories. The label includes storage instructions, capsule description as purple with white printing, and a barcode. The package contains 30 capsules and highlights that it is a prescription drug to be dispensed with a medication guide.*

FDA Label Image

7.5 (Phentermine And Topiramate Extended Release Capsul 7)

Phentermine and Topiramate Extended-Release Capsules 7.5 mg/46 mg label by Prasco Laboratories. The label provides storage instructions to keep at room temperature and protect from moisture, with a warning to keep out of reach of children. It describes the capsules as purple and yellow, with specific markings and dosage details. The package contains 30 capsules and includes a barcode and regulatory symbols.*

FDA Label Image

11.25 (Phentermine And Topiramate Extended Release Capsul 8)

Label of Phentermine and Topiramate Extended-Release Capsules, 11.25 mg/69 mg, by Prasco Laboratories. The label includes storage instructions, dosage strength, capsule description (yellow/yellow with VIVUS and strength printed), and package size of 30 capsules. It is designated Rx only with a schedule IV symbol.*

FDA Label Image

15 (Phentermine And Topiramate Extended Release Capsul 9)

Label for Phentermine and Topiramate Extended-Release Capsules, 15 mg/92 mg, by Prasco Laboratories. The label specifies storage instructions, capsule description (yellow/white, marked with 'VIVUS' and '15/92'), and quantity of 30 capsules. It includes NDC 66993-783-30 and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.